Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Xeris Biopharma Holdings Inc | 5,113,348 | 2,015,157 | -3,098,191 | $14.57M | $6.83M | 41.06% | -$7.74M |
| Rezolute, Inc.(RZLT) | 1,318,967 | 1,318,967 | 0 | $6.40M | $6.46M | 38.85% | +$65.9K |
| State Street SPDR S&P 500 ETF TrustTR UNIT(SPY) | 2,867 | 2,823 | -44 | $1.64M | $1.65M | 9.94% | +$9.6K |
| Berkshire Hathaway Inc DelCL B | 1,151 | 1,133 | -18 | $529.6K | $513.6K | 3.09% | -$16.0K |
| SPDR Gold SharesGOLD SHS(GLD) | 0 | 1,169 | +1,169 | $0 | $283.1K | 1.70% | +$283.1K |
| Mind Medicine Mindmed Inc | 34,073 | 34,073 | 0 | $193.9K | $237.1K | 1.43% | +$43.3K |
| Bicara Therapeutics Inc | 10,941 | 10,941 | 0 | $278.7K | $190.6K | 1.15% | -$88.1K |
| Lexeo Therapeutics, Inc.(LXEO) | 17,851 | 17,851 | 0 | $161.4K | $117.5K | 0.71% | -$43.9K |
| Kyverna Therapeutics, Inc.(KYTX) | 22,981 | 22,981 | 0 | $112.4K | $86.0K | 0.52% | -$26.4K |
| Compass Therapeutics, Inc.(CMPX) | 43,465 | 43,465 | 0 | $80.0K | $63.0K | 0.38% | -$17.0K |
| Cardiff Oncology, Inc.(CRDF) | 0 | 13,287 | +13,287 | $0 | $57.7K | 0.35% | +$57.7K |
| Inhibikase Therapeutics, Inc.(IKT) | 0 | 16,393 | +16,393 | $0 | $53.3K | 0.32% | +$53.3K |
| Glycomimetics Inc | 0 | 203,578 | +203,578 | $0 | $50.9K | 0.31% | +$50.9K |
| Context Therapeutics Inc.(CNTX) | 18,403 | 18,403 | 0 | $36.1K | $19.3K | 0.12% | -$16.7K |
| Adicet Bio Inc | 17,488 | 17,488 | 0 | $25.2K | $16.8K | 0.10% | -$8.4K |
| ABIVAX Société AnonymeADS(ABVX) | 11,365 | 0 | -11,365 | $130.9K | $0 | — | -$130.9K |